brentuximab vedotin
C25003
Phase 3 small_molecule completed
Quick answer
brentuximab vedotin for Hodgkin Lymphoma is a Phase 3 program (small_molecule) at Takeda with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hodgkin Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed